Atlanta Braves Holdings, Inc. (NASDAQ:BATRA – Get Free Report) major shareholder John C. Malone bought 8,371 shares of the business’s stock in a transaction on Monday, April 21st. The stock was bought at an average cost of $41.94 per share, for a total transaction of $351,079.74. Following the purchase, the insider now directly owns 371,707 shares of the company’s stock, valued at approximately $15,589,391.58. This trade represents a 2.30 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.
Atlanta Braves Stock Down 0.0 %
NASDAQ:BATRA opened at $43.29 on Friday. The company has a market cap of $2.68 billion, a PE ratio of -59.30 and a beta of 0.61. The stock has a 50-day simple moving average of $42.90 and a 200 day simple moving average of $42.27. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.70 and a current ratio of 0.70. Atlanta Braves Holdings, Inc. has a 52-week low of $38.67 and a 52-week high of $46.65.
Atlanta Braves (NASDAQ:BATRA – Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The financial services provider reported ($0.31) earnings per share for the quarter, beating the consensus estimate of ($0.78) by $0.47. Atlanta Braves had a negative return on equity of 8.48% and a negative net margin of 6.56%. The company had revenue of $52.12 million during the quarter, compared to analysts’ expectations of $48.20 million. On average, sell-side analysts expect that Atlanta Braves Holdings, Inc. will post -0.98 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Get Our Latest Stock Analysis on BATRA
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in the stock. GAMMA Investing LLC boosted its stake in shares of Atlanta Braves by 25.1% during the 1st quarter. GAMMA Investing LLC now owns 1,207 shares of the financial services provider’s stock worth $53,000 after acquiring an additional 242 shares during the period. Pacific Global Investment Management Co. increased its holdings in shares of Atlanta Braves by 5.1% in the fourth quarter. Pacific Global Investment Management Co. now owns 5,147 shares of the financial services provider’s stock valued at $210,000 after purchasing an additional 249 shares during the last quarter. Central Pacific Bank Trust Division raised its position in shares of Atlanta Braves by 2.4% in the first quarter. Central Pacific Bank Trust Division now owns 17,000 shares of the financial services provider’s stock valued at $746,000 after purchasing an additional 400 shares during the period. Northern Trust Corp raised its position in shares of Atlanta Braves by 0.5% in the fourth quarter. Northern Trust Corp now owns 95,644 shares of the financial services provider’s stock valued at $3,902,000 after purchasing an additional 436 shares during the period. Finally, Nuveen Asset Management LLC lifted its stake in shares of Atlanta Braves by 1.5% during the 4th quarter. Nuveen Asset Management LLC now owns 36,354 shares of the financial services provider’s stock worth $1,483,000 after buying an additional 540 shares during the last quarter. Institutional investors and hedge funds own 12.31% of the company’s stock.
About Atlanta Braves
Atlanta Braves Holdings, Inc owns and operates the Atlanta Braves Major league baseball club. It also operates mixed-use development project, including retail, office, hotel, and entertainment projects. The company was incorporated in 2022 and is based in Englewood, Colorado.
Recommended Stories
- Five stocks we like better than Atlanta Braves
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Short Sellers Gave Up on These 3 Names Recently
- Using the MarketBeat Dividend Yield Calculator
- 3 Boring Stocks Outperforming the Market This Year
- Russell 2000 Index, How Investors Use it For Profitable Trading
- If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
Receive News & Ratings for Atlanta Braves Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlanta Braves and related companies with MarketBeat.com's FREE daily email newsletter.